Free public records show Shenzhen Shenxin Biotechnology Co., Ltd in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Shenzhen Shenxin Biotechnology Co., Ltd or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
4 active studies led by Shenzhen Shenxin Biotechnology Co., Ltd, of 5 in all
Source: ClinicalTrials.gov, Studies with Shenzhen Shenxin Biotechnology Co., Ltd (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Shenzhen Shenxin Biotechnology Co., Ltd leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Shenzhen Shenxin Biotechnology Co., Ltd or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Shenzhen Shenxin Biotechnology Co., Ltd: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Shenzhen Shenxin Biotechnology Co., Ltd is in.
Stories on the topics Shenzhen Shenxin Biotechnology Co., Ltd works in.
TB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Read
WHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient…
Read
Drug-resistant infections already kill over a million people a year. Faster testing helps doctors pick the…
ReadSearch all reports for Shenzhen Shenxin Biotechnology Co., Ltd All companies